Acuta Capital Partners’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-23,500
| Closed | -$5.26M | – | 42 |
|
|
2023
Q1 | $5.26M | Sell |
23,500
-9,500
| -29% | -$2.13M | 3.88% | 9 |
|
|
2022
Q4 | $9.18M | Buy |
33,000
+5,500
| +20% | +$1.53M | 5.65% | 5 |
|
|
2022
Q3 | $5.76M | Buy |
27,500
+14,500
| +112% | +$3.04M | 2.48% | 14 |
|
|
2022
Q2 | $3.06M | Buy |
+13,000
| New | +$3.06M | 1.71% | 19 |
|
|
2021
Q4 | – | Sell |
-3,000
| Closed | -$554K | – | 52 |
|
|
2021
Q3 | $554K | Buy |
+3,000
| New | +$554K | 0.2% | 44 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 60 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 64 |
|